Clinical Trial Detail

NCT ID NCT01641939
Title A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

gastroesophageal junction adenocarcinoma

stomach cancer

Therapies

Docetaxel

Paclitaxel

Ado-trastuzumab emtansine

Age Groups: adult

Additional content available in CKB BOOST